Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…

Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …

Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …

Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination coverage increases in the United States, there is a need to understand the real-world …

Methods| We evaluated anti–SARS-CoV-2 antibodies at baseline and approximately 60
days later in a convenience sample of health care personnel at Vanderbilt University Medical …

Among 249 healthcare personnel who worked in hospital units with COVID-19 patients for 1
month, 19 (7.6%) tested positive for SARS-CoV-2 antibodies. Only 11 (57.9%) of the 19 …

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2
Variants in the United States: A Prospective Observational Study - PMC Back to Top Skip to …

Introduction Understanding the changing epidemiology of adults hospitalized with coronavirus
disease 2019 (COVID-19) informs research priorities and public health policies. Methods …

Background Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces cardiovascular
death and worsening heart failure in patients with chronic heart failure and reduced …

Objectives: Given finite ICU bed capacity, knowledge of ICU bed utilization during the
coronavirus disease 2019 pandemic is critical to ensure future strategies for resource allocation …